| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/02/2023 | 25.09% | Stifel | $43 → $35 | Maintains | Hold |
| 05/19/2023 | 35.81% | DA Davidson | → $38 | Reiterates | Neutral → Neutral |
| 03/01/2023 | 46.53% | Citigroup | $35 → $41 | Maintains | Neutral |
| 02/16/2023 | 35.81% | DA Davidson | $40 → $38 | Maintains | Neutral |
| 01/31/2023 | 39.39% | Jefferies | → $39 | Downgrades | Buy → Hold |
| 11/23/2022 | 21.52% | DA Davidson | $40 → $34 | Maintains | Neutral |
| 10/05/2022 | 39.39% | Citigroup | $47 → $39 | Maintains | Neutral |
| 08/23/2022 | 42.96% | DA Davidson | $45 → $40 | Maintains | Neutral |
| 08/08/2022 | 67.98% | Citigroup | $45 → $47 | Maintains | Neutral |
| 05/05/2022 | 60.83% | DA Davidson | $50 → $45 | Maintains | Neutral |
| 02/17/2022 | 78.7% | DA Davidson | $47 → $50 | Maintains | Neutral |
| 11/24/2021 | 75.13% | Citigroup | $43 → $49 | Maintains | Neutral |
| 10/06/2021 | 67.98% | DA Davidson | $61 → $47 | Maintains | Neutral |
| 02/12/2021 | 107.29% | DA Davidson | $71 → $58 | Downgrades | Buy → Neutral |
| 02/02/2021 | 135.88% | Jefferies | $60 → $66 | Maintains | Buy |
| 10/02/2020 | 143.03% | DA Davidson | $61 → $68 | Maintains | Buy |
| 10/02/2020 | — | B of A Securities | Upgrades | Underperform → Neutral | |
| 08/06/2020 | 96.57% | Stifel | $50 → $55 | Maintains | Hold |
| 07/02/2020 | 92.99% | DA Davidson | $35 → $54 | Upgrades | Neutral → Buy |
| 07/02/2020 | 78.7% | Jefferies | $42 → $50 | Upgrades | Hold → Buy |
| 06/11/2020 | 28.66% | Stifel | $35 → $36 | Maintains | Hold |
| 05/07/2020 | 3.65% | Citigroup | $25 → $29 | Maintains | Neutral |
| 05/07/2020 | 25.09% | Deutsche Bank | $28 → $35 | Maintains | Hold |
| 03/09/2020 | 0.07% | Deutsche Bank | $40 → $28 | Downgrades | Buy → Hold |
| 02/14/2020 | 17.94% | Citigroup | $43 → $33 | Maintains | Neutral |
| 02/13/2020 | 7.22% | B of A Securities | $40 → $30 | Maintains | Underperform |
| 12/05/2019 | 53.68% | Citigroup | → $43 | Assumes | → Neutral |
| 11/06/2019 | — | Citigroup | Downgrades | Buy → Neutral | |
| 10/30/2019 | — | Stifel | Upgrades | Sell → Hold | |
| 07/18/2019 | 85.85% | Citigroup | $86 → $52 | Maintains | Buy |
| 07/17/2019 | 35.81% | DA Davidson | $88 → $38 | Downgrades | Buy → Neutral |
| 05/01/2019 | — | Deutsche Bank | Upgrades | Hold → Buy | |
| 03/25/2019 | 53.68% | Stifel | $63 → $43 | Downgrades | Hold → Sell |
| 10/09/2018 | 228.81% | DA Davidson | → $92 | Initiates Coverage On | → Buy |
| 08/03/2018 | 150.18% | Stifel | $57 → $70 | Upgrades | Sell → Hold |
What is the target price for Nu Skin Enterprises (NUS)?
The latest price target for Nu Skin Enterprises (NYSE: NUS) was reported by Stifel on August 2, 2023. The analyst firm set a price target for $35.00 expecting NUS to rise to within 12 months (a possible 25.09% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nu Skin Enterprises (NUS)?
The latest analyst rating for Nu Skin Enterprises (NYSE: NUS) was provided by Stifel, and Nu Skin Enterprises maintained their hold rating.
When is the next analyst rating going to be posted or updated for Nu Skin Enterprises (NUS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nu Skin Enterprises, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nu Skin Enterprises was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.
Is the Analyst Rating Nu Skin Enterprises (NUS) correct?
While ratings are subjective and will change, the latest Nu Skin Enterprises (NUS) rating was a maintained with a price target of $43.00 to $35.00. The current price Nu Skin Enterprises (NUS) is trading at is $27.98, which is out of the analyst's predicted range.